moxifloxacin has been researched along with Iris Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 7 (53.85) | 2.80 |
| Authors | Studies |
|---|---|
| Arteaga-Rivera, K; de-la-Torre, A; Neira-Segura, N; Reyes-Guanes, J; Rivera-Valdivia, N | 1 |
| Arunkumar, WV; Lagvankar, M; Patnaik, G | 1 |
| Gürelik, G; Özdek, Ş; Özdemir, HB; Yüksel, M | 1 |
| Lončarić, K; Radmilović, M; Tadić, R; Vatavuk, Z | 1 |
| Klonner, J; Salchow, D | 1 |
| Camós-Carreras, A; Eixarch, A; Sánchez-Dalmau, B; Sánchez-Vela, L | 1 |
| Bakbak, B; Gonul, S | 1 |
| Broens, A; Collignon, N | 2 |
| Augustinus, A; Hondeghem, K; Kreps, EO; Leroy, BP; Schauwvlieghe, PP; Sys, C; Van de Veire, S | 1 |
| Belfort, R; Campos, MS; Nascimento, HM; Sousa, JM | 1 |
| Brouwers, K; De Waard, PW; Martinez Ciriano, JP; Missotten, TO; Van Aken, E; van Langenhove, L; Wefers Bettink-Remeijer, M | 1 |
| Bettis, DI; Morshedi, RG; Moshirfar, M; Vitale, AT | 1 |
1 review(s) available for moxifloxacin and Iris Diseases
| Article | Year |
|---|---|
Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature.
Topics: Adult; Aged; Anti-Infective Agents; Antihypertensive Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Iris Diseases; Male; Moxifloxacin; Ocular Hypertension; Pigment Epithelium of Eye; Quinolines; Respiratory Tract Infections; Trabecular Meshwork; Transillumination; Treatment Outcome | 2012 |
12 other study(ies) available for moxifloxacin and Iris Diseases
| Article | Year |
|---|---|
Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report.
Topics: Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Middle Aged; Moxifloxacin; Transillumination | 2021 |
Bilateral Acute Depigmentation of Iris (BADI) Post COVID Infection following Systemic Moxifloxacin Therapy.
Topics: Adult; Aged; COVID-19; Female; Humans; Iris; Iris Diseases; Moxifloxacin; RNA, Viral; SARS-CoV-2 | 2023 |
Bilateral acute Iris transillumination after COVID-19 pneumonia.
Topics: Aged; COVID-19; Humans; Iris; Iris Diseases; Male; Moxifloxacin; Transillumination | 2023 |
Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
Topics: COVID-19; Glaucoma; Humans; Iris; Iris Diseases; Moxifloxacin; Syndrome; Transillumination | 2023 |
[Unusual anisocoria].
Topics: Anisocoria; Female; Glaucoma, Open-Angle; Humans; Iris; Iris Diseases; Middle Aged; Moxifloxacin | 2021 |
Bilateral acute iris transillumination induced by moxifloxacin.
Topics: Humans; Iris; Iris Diseases; Moxifloxacin; Transillumination | 2021 |
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Topics: Glaucoma, Open-Angle; Humans; Intraocular Pressure; Iris; Iris Diseases; Moxifloxacin; Uveitis, Anterior | 2022 |
[Moxiflaxin and iris transillumination].
Topics: Acute Disease; Adult; Bronchitis; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Moxifloxacin; Pigment Epithelium of Eye | 2016 |
Is oral moxifloxacin associated with bilateral acute iris transillumination?
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Female; Fluoroquinolones; Humans; Iris; Iris Diseases; Male; Middle Aged; Moxifloxacin | 2018 |
Acute iris depigmentation following systemic moxifloxacin.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Iris Diseases; Male; Moxifloxacin; Pigmentation Disorders; Quinolines | 2013 |
[Moxifloxacin and iris transillumination].
Topics: Adult; Anti-Bacterial Agents; Female; Fluoroquinolones; Humans; Iris Diseases; Moxifloxacin; Pigment Epithelium of Eye | 2015 |
Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Iris Diseases; Male; Moxifloxacin; Photophobia; Quinolines; Transillumination; Uveitis | 2009 |